OOIR: Observatory of International Research

Papers

(The H4-Index of Current Medicinal Chemistry is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Corrigendum to: Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches	111
Challenges of Natural Anticancer and Anti-inflammatory Agents	105
Identification of Critical Genes Related to Breast Cancer with Brain Metastasis Through Bioinformatics Analysis	86
Intermittent Fasting and Fasting-mimicking Diet: Promising Strategies in Cancer Management	64
Multimodality Cardiac Imaging Biomarkers and Atrial Fibrillation Substrate: Are they Worthwhile?	60
Drug-Resistant Infections: A Global Challenge for the Future	58
Paneth Cells: Recent Updates on Elucidating Therapeutic Implications in Gastroenterological Disease Management	58
Chalcogenium-AZT Derivatives: A Plausible Strategy To Tackle The RT-Inhibitors-Related Oxidative Stress While Maintaining Their Anti- HIV Properties	57
Commentary on the Role of Medicinal Cannabis in Healthy Aging and Neuroprotection	57
Research Prospects for the Mitochondria in Glaucoma: A Bibliometric Analysis	54
MEF2C is a Potential Prognostic Biomarker and is Correlated with Immune Infiltrates in Lung Adenocarcinoma	53
Expression of TCEAL2 is a Novel Prognostic Biomarker and Potential Therapeutic Target in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	51
Potential Therapeutic Targets for the Management of Diabetes Mellitus Type 2	50
Statins, Allies against Antibiotic Resistance?	48
Development in the Inhibition of Dengue Proteases as Drug Targets	48
Revisiting the Role of B-RAF Kinase as a Therapeutic Target in Melanoma	46
Determination of the 95% Effective Dose of Remifentanil for Moderate Sedation During Gastroscopy in Obese Patients	42
TRIP13 Activates Glycolysis to Promote Cell Stemness and Strengthen Doxorubicin Resistance of Colorectal Cancer Cells	41
Role of Ferroptosis in ALD: Focusing on Hepcidin and Besides Hepcidin	41
Naturally Occurring Xanthones; Biological Activities, Chemical Profiles and In Silico Drug Discovery	40
Autophagy-related ncRNAs: Regulatory Roles and Potential Therapeutic Effects in Digestive System Neoplasms	39
Analysis and Validation of Tyrosine Metabolism-related Prognostic Features for Liver Hepatocellular Carcinoma Therapy	39
New Insights into the Long Non-coding RNAs Dependent Modulation of Heart Failure and Cardiac Hypertrophy: From Molecular Function to Diagnosis and Treatment	38
Exploring the Anticancer Potential of Astragalin in Triple Negative Breast Cancer Cells by Attenuating Glycolytic Pathway through AMPK/mTOR	35
Recent Advances in Lung Cancer Therapy Based on Nanomaterials: A Review	35

SGLT-2 Inhibitors: The Next-generation Treatment for Type 2 Diabetes Mellitus	34
Intimal Macrovascular Pericytes: Their Role in Vascular Biology and Atherogenesis	34
Potential for Novel Therapeutic Uses of Alpha Lipoic Acid	33
Prediction of Prognosis and Immunotherapy Response of Gastric Cancer Based on Glutamine Metabolism-related Genes	33
Design, Synthesis, and Pharmacological Characterization of Substituted Quinoxalines as NOP Receptor Ligands	33
Neuroinflammatory Human Brain Organoids Enable Comprehensive Drug Screening Studies: Fingolimod and its Analogues in Focus	33
Long Non-coding RNA DLGAP1-AS1 and DLGAP1-AS2: Two Novel Oncogenes in Multiple Cancers	32
Exploring the Possible Role of Gut Microbiota with Ischemic Stroke Subtypes: A Mendelian Randomization Study with Insights into Immune Cell Mediators	32